I don’t think so for prevention. They work in different ways, and I haven’t seen any data with LL and PrEP (pre-exposure prophylaxis- i.e. prevention) but theoretically LL should be able to block HIV from getting inside the cells upon an exposure. If LL does it job the way I am thinking it would then there is no need for a secondary medicine.

Historically, PrEP regimens have involved at least two medicines because of the ability for HIV to rapidly mutate and find workarounds, allowing it to replicate but maybe Ohm has a different opinion.

Now, looking at Dr. SACHA’s Slide deck from his presentation in October where he used ART (antiretroviral therapy that is considered standard treatment for HIV), bNABS and LL then yes there could be room for CAB (settle down, not that cab Respert).